These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 12544532

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.
    Byeon JS, Choi EK, Heo NY, Hong SC, Myung SJ, Yang SK, Kim JH, Song JK, Yoo B, Yu CS.
    Dis Colon Rectum; 2007 May; 50(5):672-6. PubMed ID: 17216141
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.
    Kanemaru H, Makino T, Jinnin M, Yonemitsu A, Makino K, Ihn H.
    J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-tumor necrosis factor alpha antibody in the treatment of Behçet's disease.
    Nakamura S, Ohno S.
    Int Ophthalmol Clin; 2005 Aug; 45(2):179-89. PubMed ID: 15791165
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
    Almoznino G, Ben-Chetrit E.
    Clin Exp Rheumatol; 2007 Aug; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of infliximab in intestinal Behçet's disease: a Korean multicenter retrospective study.
    Lee JH, Cheon JH, Jeon SW, Ye BD, Yang SK, Kim YH, Lee KM, Im JP, Kim JS, Lee CK, Kim HJ, Kim EY, Kim KO, Jang BI, Kim WH.
    Inflamm Bowel Dis; 2013 Aug; 19(9):1833-8. PubMed ID: 23702810
    [Abstract] [Full Text] [Related]

  • 16. Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.
    Gulli S, Arrigo C, Bocchino L, Morgante L, Sangari D, Castagna I, Bagnato GF.
    BMC Musculoskelet Disord; 2003 Aug 28; 4():19. PubMed ID: 12946278
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary artery aneurysms in Behçet's disease treated with anti-TNFα: A case series and review of the literature.
    Chan E, Sangle SR, Coghlan JG, D'Cruz DD.
    Autoimmun Rev; 2016 Apr 28; 15(4):375-8. PubMed ID: 26777307
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Psoriasis triggered by infliximab in a patient with Behçet's disease.
    Kawazoe Y, Sugita S, Yamada Y, Akino A, Miura K, Mochizuki M.
    Jpn J Ophthalmol; 2013 Jan 28; 57(1):95-7. PubMed ID: 23090423
    [Abstract] [Full Text] [Related]

  • 20. Local injection of infliximab in symptomatic isolated mucosal lesions: a novel scenario for endoscopic therapy?
    Lorenzo-Zúñiga V, Boix J, Mañosa M, Lezcano C, Cabré E, Moreno de Vega V, Domènech E.
    Inflamm Bowel Dis; 2013 Jan 28; 19(4):E59-61. PubMed ID: 22605623
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.